Kolexia
Guillemain Romain
Anesthesie-réanimation
Hôpital Européen Georges Pompidou
Paris, France
114 Activités
144 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Complications postopératoires Défaillance cardiaque Bronchiolite oblitérante Cardiopathies Bronchiolite Cardiopathies congénitales Bronchiolitis Obliterans Syndrome

Industries

Sanofi
1 collaboration(s)
Dernière en 2022
Novartis
1 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2023
Therakos
1 collaboration(s)
Dernière en 2022

Dernières activités

Long-term outcomes after heart transplantation in adult patients with univentricular versus biventricular congenital heart disease.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery   11 décembre 2023
Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation.
ESC heart failure   05 juillet 2023
Sudden cardiac death after heart transplantation: a population-based study.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology   22 mai 2023
Transcatheter Tricuspid Repair for Tricuspid Regurgitation After Heart Transplantation.
JACC. Case reports   19 avril 2023
(999) Validation of the Clinical Utility of MicroRNA as Non-Invasive Biomarkers of Cardiac Allograft Rejection Monitoring: A Prospective Longitudinal Multicenter Study
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation   01 avril 2023
Invasive bone and joint infections from the French Scedosporiosis/lomentosporiosis Observational Study (SOS) cohort: no mortality with long-term antifungal treatment and surgery.
Medical mycology   20 mars 2023
Long-term outcomes after heart transplantation in adult patients with congenital heart disease: Does initial defect and physiology impact survival?
JESFC 2023   01 janvier 2023
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19.
The Journal of antimicrobial chemotherapy   04 octobre 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   01 août 2022
Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation.
ESC heart failure   07 juillet 2022